Related Experiment Video
Updated: May 7, 2026
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
STAT transcription in the ischemic heart
Richard A Knight1, Tiziano M Scarabelli, Anastasis Stephanou
1Medical Molecular Biology Unit; University College London; London, UK.
Insights
Signal transducer and activator of transcription (STAT) proteins play dual roles in heart health. STAT1 promotes cell death, while STAT3 offers protection against ischemia but contributes to heart failure progression.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Physiology
Background:
- All seven STAT proteins are expressed in the heart.
- STAT proteins are crucial in cardiac physiology and disease.
- Their roles in ischemic heart disease are complex and multifaceted.
Purpose of the Study:
- To review the contribution of STAT proteins to cardiac physiology.
- To elucidate the roles of STAT1 and STAT3 in ischemic heart disease and its consequences.
- To understand the dualistic function of STAT proteins in cardiac myocytes.
Main Methods:
- Review of existing literature on STAT proteins in cardiac function and disease.
- Analysis of studies focusing on STAT1 and STAT3 in acute and chronic ischemic conditions.
- Examination of evidence from STAT3-deficient mouse models and cardioprotective agent studies.
Main Results:
- STAT1 exacerbates cardiac myocyte loss via apoptosis and reduced autophagy.
- STAT3 demonstrates cardioprotective effects in acute ischemia and is vital for preconditioning.
- Prolonged STAT3 activation, potentially with STAT5, promotes adverse post-infarction remodeling and heart failure.
Conclusions:
- STAT proteins, particularly STAT1 and STAT3, exhibit opposing roles in the acute phase of ischemic heart disease.
- STAT3 is essential for cardioprotection but implicated in the progression to heart failure.
- Understanding these STAT protein dynamics is key for developing therapeutic strategies for ischemic heart disease.
Abstract:
All seven STAT proteins are expressed in the heart, and in this review we will focus on their contribution to cardiac physiology and to ischemic heart disease and its consequences. A substantial literature has focused on the roles of STAT1 and STAT3 in ischemic heart disease, where, at least in the acute phase, they appear to have a yin-yang relationship. STAT1 contributes to the loss of irreplaceable cardiac myocytes both by increasing apoptosis and by reducing cardioprotective autophagy. In contrast, STAT3 is cardioprotective, since STAT3-deficient mice have larger infarcts following ischemic injury, and a number of cardioprotective agents have been shown to act, at least partly, through STAT3 activation. STAT3 is also absolutely required for preconditioning-a process where periods of brief ischemia protect against a subsequent or previous prolonged ischemic episode. Prolonged activation of STAT3, however, is strongly implicated in the post-infarction remodeling of the heart which leads to heart failure, where, possibly together with STAT5, it augments activation of the renin-angiotensin system.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Acute Coronary Syndrome I: Introduction